Loading…
CareDx, Inc. is projected to rise to $46.07 by 2027, a +21% move from its current price of $38.10. CDNA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $36.83 | $38.08 | $39.38 | -0.05% |
| Aug 2 | $36.30 | $38.06 | $39.91 | -0.09% |
| Aug 3 | $35.90 | $38.05 | $40.32 | -0.14% |
| Aug 4 | $35.56 | $38.03 | $40.67 | -0.19% |
| Aug 5 | $35.27 | $38.01 | $40.97 | -0.23% |
| Aug 6 | $35.00 | $37.99 | $41.25 | -0.28% |
| Aug 7 | $34.75 | $37.98 | $41.50 | -0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $34.75 | $37.98 | $41.50 | -0.33% |
| Week 2 | $33.39 | $37.85 | $42.91 | -0.65% |
| Week 3 | $32.36 | $37.73 | $44.00 | -0.97% |
| Week 4 | $31.49 | $37.61 | $44.91 | -1.29% |
| Week 5 | $30.74 | $37.48 | $45.71 | -1.62% |
| Week 6 | $30.07 | $37.36 | $46.43 | -1.94% |
| Week 7 | $29.45 | $37.24 | $47.09 | -2.26% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company offers a suite of tests and software, including AlloSure Kidney, AlloMap Heart, AlloSure Heart, AlloSure Lung, and HeartCare, among others.
It was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in Brisbane, California.
CareDx trades under the symbol CDNA and is a healthcare stock with a current price of $37.14 and a market capitalization of $1.92B. Rank: 1931.
The near-term price outlook for 2026 is neutral, with an average forecast of $37.14, a low of $16.05, a high of $45.02, and an ROI of 0%.
From 2027 onward, the forecast turns bullish, with average prices of $45.30 in 2027, $49.08 in 2028, and $55.99 in 2029, and a rising trajectory through 2030 ($78.55 avg, ROI 111.5%), 2040 ($255.05 avg, ROI 586.7%), and 2050 ($534.52 avg, ROI 1339.2%).
A major floor 57.9% below — a decisive break under it would weaken the trend.
The nearest floor, 38.4% below — buyers have tended to step in here.
The nearest ceiling, 5.9% above — a clean break opens room to run.
A major ceiling 33.4% above — clearing it would confirm fresh momentum.
Key CDNA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDNA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $36.55 | Buy | $36.82 | Buy |
| MA 10 | $37.48 | Buy | $36.21 | Buy |
| MA 20 | $33.71 | Buy | $34.13 | Buy |
| MA 50 | $27.87 | Buy | $29.46 | Buy |
| MA 100 | $23.47 | Buy | $25.65 | Buy |
| MA 200 | $20.81 | Buy | $22.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.55 | Neutral |
| Stoch RSI (14) | 28.73 | Neutral |
| CCI (20) | 66.04 | Neutral |
| Williams %R (14) | -19.34 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | 31.70 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 80.66 | Sell |
| TRIX (15) | 1.54 | Buy |
| Awesome (5,34) | 6.00 | Buy |
| Ultimate (7,14,28) | 57.55 | Neutral |
| Momentum (10) | -2.24 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 35.80 | Buy |
| ADX (14) | 36.28 | Buy |
| ATR (14) | 1.11 | Info |
The 30-day technical picture is bullish. RSI14 is 70, and the stock trades above both major moving averages (SMA50 at $26.28 and SMA200 at $20.26), indicating bullish momentum.
Support is at $22.97 and resistance at $40.34. The 30-day range spans from $29.60 to $46.59, reflecting active trading within a sideways-to-upward band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.05 | $38.10 | $46.12 | 0% | Neutral | |
| $35.98 | $46.07 | $62.82 | +21% | Bullish | |
| $38.31 | $50.84 | $72.49 | +33% | Bullish | |
| $42.36 | $57.89 | $85.45 | +52% | Bullish | |
| $56.72 | $79.57 | $120.89 | +109% | Bullish | |
| $68.44 | $98.34 | $153.19 | +158% | Bullish | |
| $76.72 | $112.73 | $179.58 | +196% | Bullish | |
| $79.47 | $119.26 | $193.85 | +213% | Bullish | |
| $81.45 | $124.73 | $206.53 | +227% | Bullish | |
| $89.91 | $140.36 | $236.44 | +268% | Bullish | |
| $155.10 | $264.64 | $478.71 | +595% | Bullish | |
| $273.99 | $547.38 | $1,097.18 | +13.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.05 | $38.10 | $44.48 | +0.00% |
| August 2026 | $31.38 | $37.00 | $44.79 | -2.88% |
| September 2026 | $30.65 | $36.52 | $44.92 | -1.32% |
| October 2026 | $31.16 | $37.44 | $46.65 | +2.53% |
| November 2026 | $30.75 | $37.20 | $46.83 | -0.65% |
| December 2026 | $29.81 | $36.29 | $46.12 | -2.44% |
Click any year to see its month-by-month CDNA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CDNA price prediction for 2026 points to an average of $38.10 (low $16.05, high $46.12) — a potential gain of 0% on today's $38.10. A consolidation phase looks the most probable path here.
In 2027, CDNA is projected to trade between $35.98 and $62.82, averaging $46.07 — a potential gain of +21% from today's $38.10. That is up +21% on the projected 2026 average. Momentum favours further upside here.
CareDx, Inc.'s 2028 outlook centres on $50.84, within a $38.31 to $72.49 range. That is up +10% on the projected 2027 average. That marks a +33% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, CDNA could reach as high as $85.45, with a base case around $57.89 and support toward $42.36 — roughly +52% from $38.10. Momentum favours further upside here.
Expect CDNA to range from $56.72 to $120.89 through 2030. The $79.57 average target implies a +109% move from current prices. That is up +37% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The CDNA price prediction for 2031 points to an average of $98.34 (low $68.44, high $153.19) — a potential gain of +158% on today's $38.10. Momentum favours further upside here.
In 2032, CDNA is projected to trade between $76.72 and $179.58, averaging $112.73 — a potential gain of +196% from today's $38.10. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
CareDx, Inc.'s 2033 outlook centres on $119.26, within a $79.47 to $193.85 range. That is up +6% on the projected 2032 average. That marks a +213% change versus current levels. Momentum favours further upside here.
By 2034, CDNA could reach as high as $206.53, with a base case around $124.73 and support toward $81.45 — roughly +227% from $38.10. Buyers look set to stay in control over this stretch.
Expect CDNA to range from $89.91 to $236.44 through 2035. The $140.36 average target implies a +268% move from current prices. That is up +13% on the projected 2034 average. Momentum favours further upside here.
The CDNA price prediction for 2040 points to an average of $264.64 (low $155.10, high $478.71) — a potential gain of +595% on today's $38.10. Buyers look set to stay in control over this stretch.
In 2050, CDNA is projected to trade between $273.99 and $1,097.18, averaging $547.38 — a potential gain of +13.4x from today's $38.10. That is up +107% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CDNA today (≈ 26.246719 CDNA) could be worth
$14,366.8
+$13,366.8 (+1337%) by 2050 · US Dollar
Based on the average projected CDNA price of $547.38 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDNAwould be worth at today's price.
$1,000 invested in CDNA on Jul 30, 2025 (≈ 77.7605 CDNA) would be worth
$2,962.68
+$1,962.68 (+196.3%) today · 2.96× · US Dollar
Based on a CDNA entry price of $12.86 vs. today's $38.1.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $37.61 | $1,013.03 | +1.3% |
| 1 month ago | $28.5 | $1,336.84 | +33.7% |
| 3 months ago | $21.5 | $1,772.09 | +77.2% |
| 6 months ago | $20.55 | $1,854.01 | +85.4% |
| 1 year ago | $12.86 | $2,962.68 | +196.3% |
| All time (5.0y) ago | $82.25 | $463.22 | -53.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDNA forecast.
Our base-case forecast reaches $76.00 around 2030.
Implied market cap at $76.00: $3.93B
The multi-year outlook shows strong upside potential, with a neutral stance in 2026 (avg $37.14; ROI 0) followed by bullish momentum in subsequent years. In 2027 the avg is $45.30 with ROI 22%, and in 2028 the avg is $49.08 with ROI 32.2%, while 2029 carries an avg of $55.99 and ROI 50.8%. By 2030, the avg is $78.55 with ROI 111.5%.
Continuing the trajectory, 2031 shows an avg of $95.71 (ROI 157.7%), 2032 at $109.59 (ROI 195.1%), 2033 at $116.79 (ROI 214.5%), and 2034 at $120.25 (ROI 223.8%), leading to 2035 at $136.56 (ROI 267.7%). The long view extends to 2040 with an avg of $255.05 (ROI 586.7%) and 2050 with an avg of $534.52 (ROI 1339.2%). These are estimates, not guarantees, and reflect bullish sentiment over the horizon.
Tap a question to reveal the answer.
2030 forecast: min $55.65, avg $78.55, max $120.12; ROI 111.5%; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages and positive ROI (2027 ROI 22%, 2028 32.2%, 2029 50.8%, 2030 111.5%), while 2026 is neutral. These are estimates, not guarantees.
The forecast shows a 2030 max of $120.12. Later years also show higher ceilings (e.g., 2034 max $200.73; 2040 max $465.76; 2050 max $1,083.29).
Current price $37.14; Market cap $1.92B. Rank 1931.
2040: min $147.56, avg $255.05, max $465.76; ROI 586.7%. 2050: min $262.37, avg $534.52, max $1,083.29; ROI 1339.2%.
CareDx, Inc. Community Discussion
0Share your CareDx, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.